Literature DB >> 16896276

Hyperthyroidism: a secondary cause of isolated systolic hypertension.

L Michael Prisant1, Jaspal S Gujral, Anthony L Mulloy.   

Abstract

Isolated systolic hypertension is the most common form of hypertension, especially among patients 50 years or older. What is not appreciated is that there are secondary causes of isolated systolic hypertension. Hyperthyroidism increases systolic blood pressure by decreasing systemic vascular resistance, increasing heart rate, and raising cardiac output. Potential cardiovascular consequences of hyperthyroidism include atrial arrhythmias (especially atrial fibrillation), pulmonary hypertension, left ventricular hypertrophy, and heart failure. The prevalence of hypertension is greater among hyperthyroid patients than euthyroid patients. Whether there is a blunted nocturnal decline in ambulatory blood pressure among hyperthyroid patients is more controversial. Treatment is associated with a reduction in systolic blood pressure, heart rate, and cardiac output.

Entities:  

Mesh:

Year:  2006        PMID: 16896276      PMCID: PMC8109671          DOI: 10.1111/j.1524-6175.2006.05180.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  20 in total

Review 1.  Thyroid hormone and blood pressure regulation.

Authors:  Sara Danzi; Irwin Klein
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

2.  Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III.

Authors:  S S Franklin; M J Jacobs; N D Wong; G J L'Italien; P Lapuerta
Journal:  Hypertension       Date:  2001-03       Impact factor: 10.190

3.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

4.  PLasma renin activity in syndromes of thyroid hormone excess and deficiency.

Authors:  L M Resnick; J H Laragh
Journal:  Life Sci       Date:  1982 Feb 15-22       Impact factor: 5.037

5.  The evaluation of left ventricular hypertrophy in hypertensive patients with subclinical hyperthyroidism.

Authors:  Ismet Tamer; Mehmet Sargin; Haluk Sargin; Mesut Seker; Erhan Babalik; Mustafa Tekce; Ali Yayla
Journal:  Endocr J       Date:  2005-08       Impact factor: 2.349

6.  Changes of arterial pressure in patients with hyperthyroidism during therapy.

Authors:  Czesław Marcisz; Gerard Jonderko; Eugeniusz Kucharz
Journal:  Med Sci Monit       Date:  2002-07

7.  Nocturnal blood pressure in normotensive subjects and those with white coat, primary, and secondary hypertension.

Authors:  M Middeke; J Schrader
Journal:  BMJ       Date:  1994-03-05

Review 8.  Hypertension in thyroid disorders.

Authors:  I Saito; T Saruta
Journal:  Endocrinol Metab Clin North Am       Date:  1994-06       Impact factor: 4.741

9.  The effect of age on blood pressure in hyperthyroidism.

Authors:  I Saito; K Ito; T Saruta
Journal:  J Am Geriatr Soc       Date:  1985-01       Impact factor: 5.562

10.  Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma.

Authors:  José I Botella-Carretero; Manuel Gómez-Bueno; Vivencio Barrios; Carmen Caballero; Rafael García-Robles; José Sancho; Héctor F Escobar-Morreale
Journal:  Endocr Relat Cancer       Date:  2004-06       Impact factor: 5.678

View more
  26 in total

1.  [Thyroid diseases and hypertension].

Authors:  C Spitzweg; M Reincke
Journal:  Internist (Berl)       Date:  2010-05       Impact factor: 0.743

2.  Investigation of thyroid function and blood pressure in school-aged subjects without overt thyroid disease.

Authors:  Huanhuan Chen; Qian Xi; Hao Zhang; Bin Song; Xiaoyun Liu; Xiaodong Mao; Jie Li; Hongmei Shen; Wei Tang; Jiaming Zhang; Zhiguo Wang; Yu Duan; Chao Liu
Journal:  Endocrine       Date:  2011-08-30       Impact factor: 3.633

3.  Association between thyroid abnormalities and hypertension among hospitalized US patients: data from the National Inpatient Sample.

Authors:  Sijan Basnet; Rashmi Dhital; Biswaraj Tharu; Sushil Ghimire; Dilli R Poudel
Journal:  Cardiovasc Endocrinol Metab       Date:  2018-11-14

4.  Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism.

Authors:  Gudrun Caspar-Bell; Indu Dhar; Kailash Prasad
Journal:  Mol Cell Biochem       Date:  2016-02-19       Impact factor: 3.396

Review 5.  Evaluation of hypertension in children.

Authors:  Gaurav Kapur; Rossana Baracco
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

Review 6.  Thyroid dysfunction and kidney disease: An update.

Authors:  Pedro Iglesias; María Auxiliadora Bajo; Rafael Selgas; Juan José Díez
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

7.  Thyroid stimulating hormone elevation as a predictor of long-term mortality in patients with acute myocardial infarction.

Authors:  Suk Min Seo; Yoon-Seok Koh; Hun-Jun Park; Dong Bin Kim; Sung Ho Her; Jong Min Lee; Chul Soo Park; Pum-Joon Kim; Hee Yeol Kim; Ki Dong Yoo; Doo Soo Jeon; Young Keun Ahn; Myung Ho Jeong; Wook Sung Chung; Ki-Bae Seung
Journal:  Clin Cardiol       Date:  2018-10-16       Impact factor: 2.882

Review 8.  Hyperthyroidism.

Authors:  Amanda R Doubleday; Rebecca S Sippel
Journal:  Gland Surg       Date:  2020-02

Review 9.  Thyroid and the heart.

Authors:  Ira Martin Grais; James R Sowers
Journal:  Am J Med       Date:  2014-03-22       Impact factor: 4.965

Review 10.  Adipose Tissue and Modulation of Hypertension.

Authors:  Eashita Das; Joon Ho Moon; Ju Hee Lee; Nikita Thakkar; Zdenka Pausova; Hoon-Ki Sung
Journal:  Curr Hypertens Rep       Date:  2018-09-18       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.